OncoSec Medical promotes Sharron Gargosky to chief clinical officer
Dr. Gargosky previously served as OncoSec's Head of Clinical Development and Operations, as a consultant, since February 2016.
Dr. Gargosky has over 20 years of experience in clinical development and operations in the field of pharmaceutical and biologic development having managed global programs from early research phase through the U.S. Food & Drug Administration (FDA) approval process.
Recently, Dr. Gargosky was the Chief Technical and Operations Officer at Prima Biomed where she led the immuno-oncology program in ovarian and pancreatic cancer overseeing international manufacturing, regulatory approvals, and clinical execution.
Prior to Prima Biomed, she served in positions of increasing clinical and scientific responsibility at biopharmaceutical companies including Pharmacia, Medicis, and Hyperion Therapeutics.
Dr. Gargosky received her PhD from the University of Adelaide, Australia and completed her postdoctoral fellowship at Stanford University. ■
LATEST MOVES FROM California
- Qualcomm appoints James Thompson as new CTO
- Sunworks names Charles Cargile as new CEO
- ChromaDex appoints Steven Rubin to board
- Impax Laboratories appoints Paul M. Bisaro as CEO
- Retrophin names John A. Orwin to board
More inside POST